Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia

被引：0
|
作者：
Moujaber, Tania
Tran Ben
Liow, Elizabeth
Clay, Timothy
Bennett, Geer
Kearney, Mairead
Gibberd, Alison
Gurney, Howard
机构：
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs68
引用
收藏
页码：94 / 95
页数：2
相关论文
共 50 条
  • [1] Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program
    Park, Se Hoon
    Shin, Sang Joon
    Rha, Sun Young
    Beom, Seung-Hoon
    Seo, Ho Kyung
    Keam, Bhumsuk
    Kim, Miso
    Hong, Yoon-Hee
    Yoon, Shinkyo
    Lee, Jae-Lyun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [2] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    Mansinho, Andre
    Cruz, Andreia
    Marconi, Lorenzo
    Pinto, Cidalia
    Augusto, Isabel
    ADVANCES IN THERAPY, 2023, 40 (10) : 4134 - 4150
  • [3] Avelumab as First-Line Maintenance Treatment in Locally Advanced or Metastatic Urothelial Carcinoma
    André Mansinho
    Andreia Cruz
    Lorenzo Marconi
    Cidália Pinto
    Isabel Augusto
    Advances in Therapy, 2023, 40 : 4134 - 4150
  • [4] Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Gomez Rey, Gabriel
    CURRENT ONCOLOGY, 2024, 31 (09) : 5662 - 5676
  • [5] Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study
    Grivas, Petros
    Barata, Pedro
    Moon, Helen
    Gupta, Shilpa
    Hutson, Thomas
    Sternberg, Cora N.
    Brown, Jason R.
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Katzenstein, Howard M.
    Kirker, Melissa
    Hanson, Sarah
    Liu, Frank X.
    Morris, Valerie
    Bhanegaonkar, Abhijeet
    Sonpavde, Guru P.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [6] REAL-WORLD ELIGIBILITY AND UTILIZATION OF AVELUMAB MAINTENANCE IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
    Alicia, K. Morgans
    Guru, P. Sonpavde
    Vanessa, Shih
    Phoebe, Wright
    Zsolt, Hepp
    Candice, L. Willmon
    Nancy, Chang
    Steven, Sesterhenn
    Boppudi, Naga Sai Sriteja
    Thomas, Powles
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S26 - S27
  • [7] Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab
    Morgans, Alicia K.
    Sonpavde, Guru P.
    Shih, Vanessa
    Wright, Phoebe
    Hepp, Zsolt
    Willmon, Candice L.
    Chang, Nancy N.
    Mucha, Lisa
    Naga, Sai Sriteja Boppudi
    Powles, Thomas
    CLINICAL GENITOURINARY CANCER, 2024, 23 (01)
  • [8] Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study.
    Grivas, Petros
    Barata, Pedro C.
    Moon, Helen H.
    Gupta, Shilpa
    Hutson, Thomas E.
    Sternberg, Cora N.
    Brown, Jason
    Dave, Vaidehi
    Downey, Chad
    Shillington, Alicia C.
    Katzenstein, Howard
    Kirker, Melissa
    Hanson, Sarah
    Liu, Frank X.
    Morris, Valerie A.
    Bhanegaonkar, Abhijeet
    Sonpavde, Guru P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 697 - 697
  • [9] COST-EFFECTIVENESS OF AVELUMAB AS FIRST-LINE MAINTENANCE TREATMENT FOR LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA IN FINLAND
    Karttunen, E.
    Jaaskelainen, S.
    Hervonen, P.
    Chang, J.
    Kearney, M.
    VALUE IN HEALTH, 2022, 25 (01) : S99 - S99
  • [10] READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/ mUC).
    Antonuzzo, Lorenzo
    Maruzzo, Marco
    De Giorgi, Ugo
    Santini, Daniele
    Tambaro, Rosa
    Buti, Sebastiano
    Carrozza, Francesco
    Calabro, Fabio
    Di Lorenzo, Giuseppe
    Fornarini, Giuseppe
    Iacovelli, Roberto
    Cullura, Daniela
    Messina, Carlo
    Masi, Claudia
    Ciccia, Angelo
    Fazzi, Gennaro
    Venturini, Filippo
    Colasanto, Raffaele
    Necchi, Andrea
    Bracarda, Sergio
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345